Literature DB >> 19064634

Extrapulmonary dissemination of Mycobacterium bovis but not Mycobacterium tuberculosis in a bronchoscopic rabbit model of cavitary tuberculosis.

Gueno G Nedeltchev1, Tirumalai R Raghunand, Mandeep S Jassal, Shichun Lun, Qi-Jian Cheng, William R Bishai.   

Abstract

The rabbit model of tuberculosis is attractive because of its pathophysiologic resemblance to the disease in humans. Rabbits are naturally resistant to infection but may manifest cavitary lung lesions. We describe here a novel approach that utilizes presensitization and bronchoscopic inoculation to reliably produce cavities in the rabbit model. With a fixed inoculum of bacilli, we were able to reproducibly generate cavities by using Mycobacterium bovis Ravenel, M. bovis AF2122, M. bovis BCG, M. tuberculosis H37Rv, M. tuberculosis CDC1551, and the M. tuberculosis CDC1551 DeltasigC mutant. M. bovis infections generated cavitary CFU counts of 10(6) to 10(9) bacilli, while non-M. bovis species and BCG yielded CFU counts that ranged from 10(4) to 10(8) bacilli. Extrapulmonary dissemination was almost exclusively noted among rabbits infected with M. bovis Ravenel and AF2122. Though all of the species yielded secondary lesions at intrapulmonary sites, M. bovis infections led to the most apparent gross pathology. Using the M. tuberculosis icl and dosR gene expression patterns as molecular sentinels, we demonstrated that both the cavity wall and cavity lumen are microenvironments associated with hypoxia, upregulation of the bacterial dormancy program, and the use of host lipids for bacterial catabolism. This unique cavitary model provides a reliable animal model to study cavity pathogenesis and extrapulmonary dissemination.

Entities:  

Mesh:

Year:  2008        PMID: 19064634      PMCID: PMC2632025          DOI: 10.1128/IAI.01132-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary.

Authors:  Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 2.  Clinical practice. Latent tuberculosis infection.

Authors:  Robert M Jasmer; Payam Nahid; Philip C Hopewell
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  Mycobacterium tuberculosis virulence: lipids inside and out.

Authors:  Sabine Ehrt; Dirk Schnappinger
Journal:  Nat Med       Date:  2007-03       Impact factor: 53.440

4.  Prevention of tuberculous cavity formation by desensitization with tuberculin-active peptide.

Authors:  Y Yamamura; Y Ogawa; H Maeda; Y Yamamura
Journal:  Am Rev Respir Dis       Date:  1974-06

5.  Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.

Authors:  I Kramnik; W F Dietrich; P Demant; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.

Authors:  J D McKinney; K Höner zu Bentrup; E J Muñoz-Elías; A Miczak; B Chen; W T Chan; D Swenson; J C Sacchettini; W R Jacobs; D G Russell
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.

Authors:  M I Voskuil; K C Visconti; G K Schoolnik
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

8.  Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.

Authors:  Ronggai Sun; Paul J Converse; Chiew Ko; Sandeep Tyagi; Norman E Morrison; William R Bishai
Journal:  Mol Microbiol       Date:  2004-04       Impact factor: 3.501

9.  Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice.

Authors:  Petros C Karakousis; Tetsuyuki Yoshimatsu; Gyanu Lamichhane; Samuel C Woolwine; Eric L Nuermberger; Jacques Grosset; William R Bishai
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

10.  Tuberculosis of rabbits induced by droplet nuclei infection; initial response to infection.

Authors:  H L RATCLIFFE; W F WELLS
Journal:  J Exp Med       Date:  1948-06-01       Impact factor: 14.307

View more
  29 in total

Review 1.  Comparative genomics of mycobacteria: some answers, yet more new questions.

Authors:  Marcel A Behr
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

2.  Tuberculosis immunopathology: the neglected role of extracellular matrix destruction.

Authors:  Paul T Elkington; Jeanine M D'Armiento; Jon S Friedland
Journal:  Sci Transl Med       Date:  2011-02-23       Impact factor: 17.956

Review 3.  The non-human primate model of tuberculosis.

Authors:  D Kaushal; S Mehra; P J Didier; A A Lackner
Journal:  J Med Primatol       Date:  2012-03-20       Impact factor: 0.667

4.  Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.

Authors:  Emily R Driver; Gavin J Ryan; Donald R Hoff; Scott M Irwin; Randall J Basaraba; Igor Kramnik; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

5.  In vivo prediction of tuberculosis-associated cavity formation in rabbits.

Authors:  Brian Luna; André Kubler; Christer Larsson; Brent Foster; Ulas Bagci; Daniel J Mollura; Sanjay K Jain; William R Bishai
Journal:  J Infect Dis       Date:  2014-08-12       Impact factor: 5.226

6.  Immune responses in cattle inoculated with Mycobacterium bovis, Mycobacterium tuberculosis, or Mycobacterium kansasii.

Authors:  W R Waters; A O Whelan; K P Lyashchenko; R Greenwald; M V Palmer; B N Harris; R G Hewinson; H M Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

7.  Repetitive Aerosol Exposure Promotes Cavitary Tuberculosis and Enables Screening for Targeted Inhibitors of Extensive Lung Destruction.

Authors:  Michael E Urbanowski; Elizabeth A Ihms; Kristina Bigelow; André Kübler; Paul T Elkington; William R Bishai
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

8.  13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.

Authors:  Mandeep S Jassal; Gueno G Nedeltchev; Jong-Hee Lee; Seong Won Choi; Viorel Atudorei; Zachary D Sharp; Vojo Deretic; Graham S Timmins; William R Bishai
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

9.  Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas.

Authors:  Smriti Mehra; Bapi Pahar; Noton K Dutta; Cecily N Conerly; Kathrine Philippi-Falkenstein; Xavier Alvarez; Deepak Kaushal
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

10.  Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus).

Authors:  Laura E Via; Danielle M Weiner; Daniel Schimel; Philana Ling Lin; Emmanuel Dayao; Sarah L Tankersley; Ying Cai; M Teresa Coleman; Jaime Tomko; Praveen Paripati; Marlene Orandle; Robin J Kastenmayer; Michael Tartakovsky; Alexander Rosenthal; Damien Portevin; Seok Yong Eum; Saher Lahouar; Sebastien Gagneux; Douglas B Young; Joanne L Flynn; Clifton E Barry
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.